Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

RTTNews | il y a 859
Stocktwits
Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

(RTTNews) - Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.

EGFR inhibitors are critical therapeutic agents for the treatment of non-small cell lung cancer (NSCLC), pancreatic cancer, colorectal cancer, squamous-cell carcinoma of the head and neck, and breast cancer.

The company said this trial brings us one step closer to a new treatment option for underserved cancer patients as there is no specific treatment currently approved for the treatment of skin toxicities associated with EGFRi therapies.

The company added it will advance HT-001 into the clinical phase as it is a key treatment in the onco-dermatology space and anticipates beginning the Phase 2a trial in the first quarter of 2023.

Tags: HOTH
Stocktwits
read more
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews | il y a 603
Yen Slides Against Majors

Yen Slides Against Majors

The Japanese yen weakened against other major currencies in the Asian session on Wednesday.
RTTNews | il y a 36 minutes
China Unveils Monetary Easing Measures

China Unveils Monetary Easing Measures

The People's Bank of China reduced its benchmark interest rate and reserve requirement ratio and also unveiled a slew of measures to support economy hit by trade tariffs. The PBoC cut the 7-day reverse repo rate by 10 basis points to 1.4 percent. The new rate takes effect on May 8.
RTTNews | il y a 52 minutes
European Shares Seen Up As China Eases Policy To Boost Growth

European Shares Seen Up As China Eases Policy To Boost Growth

European stocks are seen opening broadly higher on Wednesday after chipmaker AMD reported better-than-expected earnings results and Chinese authorities announced a raft of stimulus measures, including interest rate cuts and a major liquidity injection, to help boost the economy.
RTTNews | il y a 2h 33min
European Economic News Preview: Germany Factory Orders Data Due

European Economic News Preview: Germany Factory Orders Data Due

Factory orders and construction Purchasing Managers' survey results from Germany are due on Wednesday, headlining a light day for the European economic news. At 2.00 am ET, Destatis is scheduled to issue Germany's factory orders data for March. Orders are forecast to grow 1.4 percent month-on-month, after remaining flat in February.
RTTNews | il y a 2h 49min
Sensex, Nifty Marginally Higher In Cautious Trade

Sensex, Nifty Marginally Higher In Cautious Trade

Indian shares were flat to slightly higher on Wednesday after the Indian Armed Forces launched precision missile strikes under 'Operation Sindoor', targeting nine terrorist sites in Pakistan and Pakistan-occupied Kashmir (PoK) in a strong response to the brutal Pahalgam terror attack.
RTTNews | il y a 3h 43min
Outils
Calendrier Économique
Market Hours
Interest Rates
Holidays Calendar
Marchés Forex
Volatilité Forex
Corrélation Forex
Actualités du Forex
forex analysis
Données COT
Liquidité
Calculatrices Forex
Heat Map du Forex
Indicators Heatmap
Communauté
Communauté
Systèmes
Systèmes les plus populaires
Stratégies
Concours
Graphiques Forex
Sentiment Forex
Indicateur de perspectives
Revues
Courtiers
Prop Trading Firms
Services SPV
Fournisseur de signaux
Services de programmation EA
Affiliate Programs
Services de courtage PAMM
Remise de services de programme
Plateformes de trading
Conseillers Experts
Marchés de crypto-monnaies
Trading Courses
Courtiers
Spreads de Forex
Cotations de courtiers Forex
Swaps de courtiers Forex
Volume du courtier Forex
Promotions des courtiers Forex Press Release
Plateforme
Widgets
Fonctionnalités
API
RSS
Stock Portfolio
Affiliate Software
Graphiques avancés
Support
FAQ
Aide
Contactez-nous
Signaler un bug!
À propos de
Blog
&copier; 2025 Myfxbook Ltd. Tous droits réservés.
AVERTISSEMENT SUR LE RISQUE ÉLEVÉ : Le trading de devises comporte un niveau de risque élevé qui peut ne pas convenir à tous les investisseurs. Leffet de levier crée un risque supplémentaire et une exposition aux pertes. Avant de décider de négocier des devises, examinez attentivement vos objectifs dinvestissement, votre niveau dexpérience et votre tolérance au risque. Vous pourriez perdre une partie ou la totalité de votre investissement initial. Ninvestissez pas largent que vous ne pouvez pas vous permettre de perdre. Renseignez-vous sur les risques associés au trading de devises et demandez conseil à un conseiller financier ou fiscal indépendant si vous avez des questions. Toutes les données et informations sont fournies "en létat", uniquement à titre dinformation, et ne sont pas destinées à des fins de trading ou de recommandation. Les performances passées ne sont pas indicatives des résultats futurs.